THE CHEMOTHERAPY FOUNDATION

Dr. Roy Herbst is our 2024 Ezra Greenspan Award recipient! The annual Ezra Greenspan Award is named in memory of the pioneering oncologist who founded The Chemotherapy Foundation in 1968. Dr. Herbst is Deputy Director and Chief of Medical Oncology at the Yale Cancer Center, Chief of Medical Oncology at Smilow Cancer Hospital, and Director of the Center for Thoracic Cancers at Yale Cancer Center and Smilow Cancer Hospital. He is Assistant Dean for Translational Research at Yale School of Medicine. Dr. Herbst is nationally recognized for his leadership and expertise in lung cancer treatment and research. His mission is the enhanced integration of clinical, laboratory, and research programs, making him a pioneer in identifying biomarkers to bring novel targeted treatments and immunotherapies to patients with advanced stage lung cancers. This work led to the approval of several therapies such as gefitinib, cetuximab, bevacizumab, axitinib, which have revolutionized the field and greatly enhanced patient survival. We are honored to have Dr. Herbst part of our Medical Advisory Council and to present him this award. The Ezra Greenspan Award was presented by Dr. Rob Winn, MD. #InnovationGala #CancerResearch

#PancreaticCancer is the third leading cause of cancer-related deaths in the United States. With approximately 64,000 new cases expected this year, it often remains undetected until advanced stages due to vague symptoms such as abdominal pain, weight loss, and jaundice. The current 5-year survival rate is only 12%, emphasizing the critical need for early detection and improved treatment options. Raising awareness is essential in the fight against pancreatic cancer! By sharing information and supporting research, we can work towards better outcomes for those affected by this disease. #PancreaticCancer #CancerAwareness #CancerInnovation #EarlyDetection #CancerResearch

Last night, The Chemotherapy+ Foundation’s 2024 Innovation Gala shone a spotlight on the incredible strides in cancer research and patient care. We were honored to recognize Dr. Roy Herbst, recipient of the Ezra Greenspan Award for his groundbreaking work in lung cancer treatment, AstraZeneca and Arun Krishna with the Pillar of Medical Advancement Award for their transformative contributions to oncology, and Seth Rudetsky, recipient of the Inspire NYC Award for his remarkable efforts in raising awareness and support for cancer. Thank you to our engaging speakers, including Dr. Rob Winn, Dr. William Oh, and Dr. Katerina Politi who inspired us with their expertise and dedication. We were deeply moved by Paola Muggia, our Executive Director, who bravely shared her personal battle with ovarian cancer, shedding light on the importance of early detection and advocacy. Her courage and dedication to our mission continue to inspire us all. This unforgettable evening would not have been possible without the support of our generous sponsors, including PIM Brands, Welch's, Stifel Financial Corp., AstraZeneca, Northwell Health Cancer Institute, Yale Cancer Center, The Tisch Cancer Institute, Oncolys BioPharma and many others. Your contributions empower us to continue our mission to transform cancer research and therapies. To our donors and attendees: thank you for making an impact. Together, we’re advancing treatments and offering hope to countless patients and families. To learn more or donate, please visit: https://lnkd.in/eaizxsyV

Dr. Larry Norton, a member of our Medical Advisory Council and Breast Cancer Research Foundation (BCRF) Founding Scientific Director has dedicated his life to the eradication of cancer. BCRF recently held its annual Symposium & Awards Luncheon to honor our global group of 260+ breast cancer investigators, which raised $2.75 million for lifesaving research. Researchers discussed the latest advancements in breast cancer research and brought together hundreds of supporters to raise critical funds that are helping to support the next breakthroughs. We are proud to have Dr. Norton as part of our TCF Medical Advisory Council and celebrate this outstanding achievement! To learn more about our Medical Advisory Council please visit: https://lnkd.in/ed6aCiFU #InnovationGala #CancerInnovation #CancerResearch

The Chemotherapy+ Foundation is at the forefront of the fight against cancer, driving breakthroughs, and supporting innovative research. Be part of the cure. Sign up for our newsletter to stay updated on our latest research, events, and more: https://lnkd.in/eZJ7Y4ta Together, we can make a difference. #CancerResearch #StayConnected #CancerAwareness

Let's talk about Lung Cancer. The two main types are non-small cell lung cancer (NSCLC), which makes up about 85% of cases, and small cell lung cancer (SCLC), which is more aggressive and fast-growing. Lung cancer impacts millions of lives. By sharing information, raising awareness, and encouraging early detection, you can help save lives! #CancerAwareness #EarlyDetection #PreventativeHealth #CancerResearch

Meet Jo Knight, a breast cancer survivor who’s turned her experience into hope and help for others. ??After battling cancer herself, Jo founded Preloved Reloved Cancer and Beyond, a volunteer service providing essential items like wigs, mastectomy bras, and pillows to cancer patients in need—free of charge. ? For Jo, this work isn’t just about providing comfort; it’s about lifting others’ spirits during the hardest times. “It fills my heart with joy to help others,” she says. ? Through her care packages, Jo brings more than just practical support—she offers an emotional boost, reminding others they’re not alone. ??She’s a true inspiration, creating a safe space for survivors to connect, share, and heal. source: BBC News ?#BreastCancer #CancerAwareness #CancerSurvivors #CancerCare

Next Tuesday join us at this year's 2024 Innovation Gala. For over 55 years, The Chemotherapy+ Foundation has identified, developed, and sustained emerging research talent in oncology, with a focus on funding translational and collaborative research projects. Our goal is to turn sparks of innovation into real breakthroughs, transforming cancer journeys for the better. Throw back to last year's event featuring Board of Trustees Member Eric Richter! For Reservations and Information Please Contact: Christine Madden: 212-725-7139, [email protected] Paola G. Muggia: 212-213-9292, [email protected] Purchase Tickets: https://lnkd.in/ePzGUSvs #InnovationGala #CancerAwareness #CancerResearch #NYCEvents

November is #LungCancerAwarenessMonth. Lung cancer is the second most common cancer worldwide. While smoking remains the leading cause, lung cancer also affects non-smokers, with adenocarcinoma being the most common form in this group. Early detection and treatment can make a life-saving difference. Let’s come together this month to raise awareness, support research, and stand with those fighting lung cancer. #LungCancer #CancerAwareness?#CancerInnovation #CancerPrevention

We are proud to announce AstraZeneca as this year's Pillar of Medical Advancement Award at this year's 2024 Innovation Gala! We proudly recognize AstraZeneca for their leadership in lung cancer treatment. The award will be accepted by Dr. Arun Krishna, Vice-President and Franchise Head of U.S. Oncology Lung Cancer. Together, we celebrate the innovations shaping the future of medicine. For over 55 years, The Chemotherapy Foundation has identified, developed, and sustained emerging research talent in oncology, with a focus on funding translational and collaborative research projects. Our goal is to turn sparks of innovation into real breakthroughs, transforming cancer journeys for the better. #InnovationGala #CancerInnovation #CancerResearch